Updated on: July 29, 2025
Neutropenic fever is a potentially life-threatening condition commonly seen in immunocompromised patients, especially those undergoing chemotherapy. Early identification, precise documentation, and timely intervention are vital for patient outcomes—and getting the ICD-10 coding right plays a major role in both treatment planning and reimbursement.
In this clinical guide, we’ll walk you through:
-
What neutropenic fever is and why it’s critical
-
ICD-10 coding using D70.9 – Neutropenia, unspecified
-
Clinical guidelines for managing febrile neutropenia
-
Documentation best practices
-
How DocScrib simplifies charting for complex oncology patients
What is Neutropenic Fever?
Neutropenic fever (also known as febrile neutropenia) is defined as:
-
A single oral temperature ≥38.3°C (101°F) or a sustained temperature ≥38.0°C for over 1 hour
-
In a patient with an absolute neutrophil count (ANC) <500/μL or expected to fall below 500
This condition most frequently affects patients receiving chemotherapy, but can also occur in those with aplastic anemia, autoimmune diseases, or bone marrow disorders.
Why It Matters
Neutrophils are the body’s first line of defense. Without them, even minor infections can escalate rapidly. For oncology patients, neutropenic fever is an oncologic emergency requiring urgent attention and often hospitalization.
ICD-10 Coding for Neutropenic Fever: D70.9 and Beyond
Accurate coding helps ensure that:
-
Providers are reimbursed for complex care
-
Clinical acuity is appropriately reflected
-
Risk scores and hospital readmission metrics are captured correctly
Primary ICD-10 Code
D70.9 – Neutropenia, unspecified
Use this when:
-
Patient presents with fever and low neutrophils
-
The cause of neutropenia is unknown or multifactorial
-
No more specific subclass (e.g., congenital, drug-induced) fits
Related ICD-10 Codes
ICD-10 Code | Description |
---|---|
D70.1 | Agranulocytosis secondary to cancer therapy |
R50.9 | Fever, unspecified (to capture fever symptom) |
Z51.11 | Encounter for antineoplastic chemotherapy |
C00–C97 | Primary cancer site (e.g., C50.911 for breast cancer) |
These codes may be used in combination with D70.9 to reflect the full clinical picture.
Charting Febrile Neutropenia in the EHR
Poor documentation often leads to claim denials, miscoded hospital stays, and under-recognized acuity. To avoid this, ensure your documentation answers these questions:
-
What is the ANC?
-
When did the fever start?
-
What is the suspected or confirmed source of infection?
-
Is the neutropenia chemotherapy-related?
-
What treatments (IV antibiotics, G-CSF, isolation) were initiated?
Sample Progress Note: Febrile Neutropenia
Subjective:
“Patient reports chills, malaise, and low-grade fever over the past 6 hours. Recent chemotherapy (5 days ago).”
Objective:
T = 38.5°C. ANC = 420/μL. BP = 102/64. WBC = 1.2 x10^9/L. No localizing signs of infection.
Assessment:
Febrile neutropenia secondary to chemotherapy.
ICD-10: D70.9, Z51.11, R50.9
Plan:
-
Admit to oncology ward
-
Start empiric IV piperacillin-tazobactam
-
Blood cultures x2
-
Monitor ANC and hemodynamics
-
Initiate G-CSF support
Causes of Neutropenic Fever
The most common trigger is chemotherapy-induced neutropenia, but febrile neutropenia may result from:
-
Hematologic malignancies (e.g., AML, lymphoma)
-
Post-bone marrow transplant state
-
Viral infections (CMV, EBV)
-
Drug-induced marrow suppression (e.g., antibiotics, antipsychotics)
In ~50% of cases, no clear infectious cause is found, yet empirical antibiotics are still life-saving.
Diagnostic and Treatment Guidelines
The IDSA (Infectious Diseases Society of America) and ASCO recommend:
Immediate Workup
-
CBC with differential
-
Two sets of blood cultures
-
Urinalysis and culture
-
Chest X-ray
-
Site-specific imaging if symptoms present
Initial Management
-
Broad-spectrum IV antibiotics within 1 hour of presentation
(e.g., cefepime, piperacillin-tazobactam) -
Avoid delay even if cultures are pending
-
Consider G-CSF for ANC recovery
-
Isolation precautions if ANC <100
Risk Stratification Tools: MASCC and CISNE Scores
These scores help determine if outpatient treatment is safe.
Score | Interpretation |
---|---|
MASCC ≥ 21 | Low risk → consider outpatient care |
CISNE 0–2 | Low risk → possible home antibiotics |
High risk | Requires inpatient management |
Febrile Neutropenia in Pediatrics vs Adults
Pediatric oncology patients often present differently, and require:
-
Weight-based dosing
-
More vigilant infection screening
-
Parental education and emergency protocols
In contrast, adults with comorbidities (e.g., diabetes, heart failure) may deteriorate faster and require ICU-level care.
Long-Term Complications
Untreated or poorly managed neutropenic fever can lead to:
-
Sepsis or septic shock
-
Multi-organ dysfunction
-
Extended hospitalizations
-
Delays in chemotherapy, impacting cancer prognosis
How AI Scribes like DocScrib Can Help
Charting for febrile neutropenia is time-sensitive, detail-heavy, and often complicated by EHR navigation. That’s where DocScrib comes in.
DocScrib Features Tailored for Oncology:
✅ Captures symptom onset, vitals, and lab data in real time
✅ Suggests appropriate ICD-10 codes like D70.9, Z51.11, and R50.9
✅ Formats SOAP, progress, or admission notes in seconds
✅ Reduces charting time and enhances audit-readiness
✅ Integrates with oncology EMR systems
Experience seamless, AI-powered documentation—
👉 Book your free demo now
Quick Reference Chart: Febrile Neutropenia ICD-10 Coding
Scenario | ICD-10 Code(s) |
---|---|
Neutropenic fever (cause unclear) | D70.9, R50.9 |
Chemo-induced neutropenia | D70.1, Z51.11, R50.9 |
Febrile neutropenia + breast CA | D70.9, C50.911, Z51.11, R50.9 |
Infection confirmed (e.g., UTI) | D70.9, N39.0, R50.9 |
Febrile neutropenia in transplant | D70.9, Z94.81 (BMT status), R50.9 |
FAQs
Q1: Is neutropenic fever an emergency?
Yes. Delayed treatment increases the risk of sepsis and death. IV antibiotics should be started within 1 hour.
Q2: Can I use D70.9 and R50.9 together?
Yes. D70.9 codes for neutropenia; R50.9 captures the fever. Together, they describe febrile neutropenia.
Q3: Can DocScrib automatically detect and code febrile neutropenia?
Yes. DocScrib’s AI engine recognizes structured symptom patterns and suggests appropriate codes for documentation and billing.
Q4: What if no infection is found?
Empirical treatment is still necessary. Documentation should reflect “fever of unknown origin in setting of neutropenia.”
Q5: How does this impact chemotherapy scheduling?
Febrile neutropenia often leads to dose delays or reductions, affecting treatment outcomes. Accurate tracking and documentation are key.
Conclusion
Neutropenic fever is not just another oncology complication—it’s an emergency. Accurate documentation using ICD-10 D70.9 and associated codes helps ensure rapid treatment, improves reimbursement accuracy, and supports better care coordination.
Whether you’re an oncologist, hospitalist, or nurse practitioner, streamlining your workflow with DocScrib can transform the way you manage complex cases like febrile neutropenia.